1 Craig WA.Pharmacokinetic Pharmacyodynamic parameters :rationale for antibacterial dosing of mice and men [J].Clin Infect Dis, 1998;26:1-10. 2 Forrest A, Nix D, Ballow C, et al.Pharmacodynamic of intravennous ciprofloxacin in seriously ill patients [J].Antimicrob Agents Chemother, 1993;37 :1073-1081. 3 Dong Y, Zhao X, Domagala J, et al.Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus [J].Antimicrob Agents Chemother, 1999;43:1756-1758. 4 Zhao X, Drlica K.Restricting the selection of antibiotic-resistant mutants:a general strategy derived from fluoroquinolones studies [J].Clin Infect Dis, 2001;33:S147-S156. 5 崔俊昌, 刘又宁, 王睿, 等.4 种氟喹诺酮类药物对金黄色葡萄球菌的防耐药变异浓度 [J].中华医学杂志, 2004;84: 1863-1866. 6 崔俊昌, 刘又宁, 王睿, 等.左氧氟沙星对兔组织笼金黄 色葡萄球菌感染的疗效研究 [J].中国临床药理学与治疗 学, 2007;12:291-294. 7 童卫杭, 柴栋, 崔俊昌, 等.兔感染性模型组织液中左氧氟沙星浓度的HPLC 测定 [J].中国抗生素杂志, 2005;30: 759-761. 8 Drlica K, Zhao X, Blondeau JM, et al.Low correlation between MIC and mutant prevention concentration [J].Antimicrob Agents Chemother, 2006;50:403-404. 9 Ofofsson FK, Marcusson LL, Komp Lindgren P, et al.Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model:relation between drug exposure and mutant prevention concentration [J].J Antimicrob Chemother, 2006;57:1116-1121. 10 Allen GP, Kaatz GW, Rybak MJ.In vitro activities of mutant prevention concentration-targeted concentrations of fluoroquinolones against Staphylococcus aureus in a pharmacodynamic model [J].Int J Antimicrob Agents, 2004;24:150-160. 11 Zinner SH, Lubenko IY, Gilbert D, et al.Emergence of resistant Streptococcus pneumoniae in an in vitro dynamicmodel that simulates moxifloxacin concentrations inside and outside the mutant selection window :related changes in susceptibility, resistance frequency and bacterial killing [J].J Antimicrob Chemother, 2003;52:616-622. 12 Firsov AA, Vostrov SN, Lubenko IY, et al.In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus [J]. Antimicrob Agents Chemother, 2003;47 :1604-1613. |